O-2545

O-2545

Systematic (IUPAC) name
(6aR,10aR)-6a,7,10,10a-Tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
Clinical data
Legal status	Unscheduled
Identifiers
CAS Registry Number	874745-42-3 Y
ChemSpider	22938186 N
Chemical data
Formula	C26H36N2O2
Molecular mass	408.575 g/mol
SMILES CC1=CC[C@H]2[C@@](Oc3c(c(cc(c3)C(CCCCn4cncc4)(C)C)O)[C@@H]2C1)(C)C
InChI InChI=1S/C26H36N2O2/c1-18-8-9-21-20(14-18)24-22(29)15-19(16-23(24)30-26(21,4)5)25(2,3)10-6-7-12-28-13-11-27-17-28/h8,11,13,15-17,20-21,29H,6-7,9-10,12,14H2,1-5H3/t20-,21-/m1/s1  N Key:RZGSWWCABDVBGX-NHCUHLMSSA-N  N
N (what is this?)  (verify)

O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water soluble, which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB₁ and CB₂ receptors, with K_i values of 1.5nM at CB₁ and 0.32nM at CB₂.^[1]

See also

• O-2113
• O-2372
• Tropoxane

References